Acrobat Genomics
PrivateLast Round
Grant
Apr 29, 2026
Total Funding Raised
$228,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Acrobat Genomics is a biotechnology company that develops a drug discovery platform using AI and high-throughput CRISPR gene-editing precision technology to create new therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acrobat Genomics Comparables
Compare Acrobat Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cassidy Bio | 78% | |
| Profluent Bio | 71% | |
| Arbor Biotechnologies | 71% | |
Acrobat Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 29, 2026 | ||||
| Seed | Dec 12, 2022 | ||||
| Accelerator | Sep 14, 2022 |
Acrobat Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| NIH RADx | Grant |
| First In | Seed |
| Defense Advanced Research Projects Agency | Grant |
| Reinforced Ventures | Seed |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Received funding from the Defense Advanced Research Projects Agency.
- Jan 28, 2026
Monthly visitors increased 54% MoM.
Acrobat Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acrobat Genomics's valuation, stock price, and market status.